These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
Ohio
|
|
1-434
|
|
31-0411980
|
|
(State of Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification Number)
|
|
One Procter & Gamble Plaza, Cincinnati, Ohio
|
|
45202
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
|
|
Large accelerated filer
|
þ
|
|
|
Accelerated filer
|
¨
|
|
|
|
Non-accelerated filer
|
¨
|
(Do not check if smaller reporting company)
|
||||
|
|
|
|
|
|
Smaller reporting company
|
¨
|
|
|
|
|
|
|
|
Emerging growth company
|
¨
|
|
|
Item 1.
|
Financial Statements
|
|
|
Three Months Ended December 31
|
|
Six Months Ended December 31
|
||||||||||||
|
Amounts in millions except per share amounts
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
NET SALES
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Cost of products sold
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Selling, general and administrative expense
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
OPERATING INCOME
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Interest expense
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Interest income
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Other non-operating income/(expense), net
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||
|
EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Income taxes on continuing operations
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
NET EARNINGS FROM CONTINUING OPERATIONS
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
NET EARNINGS FROM DISCONTINUED OPERATIONS
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
NET EARNINGS
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Less: Net earnings attributable to noncontrolling interests
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
BASIC NET EARNINGS PER COMMON SHARE
(1)
|
|
|
|
|
|
|
|
||||||||
|
Earnings from continuing operations
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Earnings from discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
BASIC NET EARNINGS PER COMMON SHARE
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
DILUTED NET EARNINGS PER COMMON SHARE
(1)
|
|
|
|
|
|
|
|
||||||||
|
Earnings from continuing operations
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Earnings from discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
DILUTED NET EARNINGS PER COMMON SHARE
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
DIVIDENDS PER COMMON SHARE
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Diluted Weighted Average Common Shares Outstanding
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
(1)
|
|
|
|
Three Months Ended December 31
|
|
Six Months Ended December 31
|
||||||||||||
|
Amounts in millions
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
NET EARNINGS
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX
|
|
|
|
|
|
|
|
||||||||
|
Financial statement translation
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||
|
Unrealized gains/(losses) on hedges
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
||||
|
Unrealized gains/(losses) on investment securities
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||
|
Unrealized gains/(losses) on defined benefit retirement plans
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||
|
TOTAL COMPREHENSIVE INCOME
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Less: Total comprehensive income attributable to noncontrolling interests
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Amounts in millions
|
|
|
|
|
December 31, 2017
|
|
June 30, 2017
|
|||||
|
Assets
|
|
|
|
|
|
|
|
|||||
|
CURRENT ASSETS
|
|
|
|
|
|
|
|
|||||
|
Cash and cash equivalents
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
Available-for-sale investment securities
|
|
|
|
|
|
|
|
|
|
|||
|
Accounts receivable
|
|
|
|
|
|
|
|
|
|
|||
|
INVENTORIES
|
|
|
|
|
|
|
|
|||||
|
Materials and supplies
|
|
|
|
|
|
|
|
|
|
|||
|
Work in process
|
|
|
|
|
|
|
|
|
|
|||
|
Finished goods
|
|
|
|
|
|
|
|
|
|
|||
|
Total inventories
|
|
|
|
|
|
|
|
|
|
|||
|
Prepaid expenses and other current assets
|
|
|
|
|
|
|
|
|
|
|||
|
TOTAL CURRENT ASSETS
|
|
|
|
|
|
|
|
|
|
|||
|
PROPERTY, PLANT AND EQUIPMENT, NET
|
|
|
|
|
|
|
|
|
|
|||
|
GOODWILL
|
|
|
|
|
|
|
|
|
|
|||
|
TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET
|
|
|
|
|
|
|
|
|
||||
|
OTHER NONCURRENT ASSETS
|
|
|
|
|
|
|
|
|
|
|||
|
TOTAL ASSETS
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Liabilities and Shareholders' Equity
|
|
|
|
|
|
|
|
|||||
|
CURRENT LIABILITIES
|
|
|
|
|
|
|
|
|||||
|
Accounts payable
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
Accrued and other liabilities
|
|
|
|
|
|
|
|
|
|
|||
|
Debt due within one year
|
|
|
|
|
|
|
|
|
|
|||
|
TOTAL CURRENT LIABILITIES
|
|
|
|
|
|
|
|
|
|
|||
|
LONG-TERM DEBT
|
|
|
|
|
|
|
|
|
|
|||
|
DEFERRED INCOME TAXES
|
|
|
|
|
|
|
|
|
|
|||
|
OTHER NONCURRENT LIABILITIES
|
|
|
|
|
|
|
|
|
|
|||
|
TOTAL LIABILITIES
|
|
|
|
|
|
|
|
|
|
|||
|
SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|||||
|
Preferred stock
|
|
|
|
|
|
|
|
|
|
|||
|
Common stock – shares issued –
|
December 2017
|
|
|
|
|
|
|
|
||||
|
|
June 2017
|
|
|
|
|
|
|
|
|
|
||
|
Additional paid-in capital
|
|
|
|
|
|
|
|
|
|
|||
|
Reserve for ESOP debt retirement
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|||
|
Accumulated other comprehensive income/(loss)
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|||
|
Treasury stock
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|||
|
Retained earnings
|
|
|
|
|
|
|
|
|
|
|||
|
Noncontrolling interest
|
|
|
|
|
|
|
|
|
|
|||
|
TOTAL SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
|
|||
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
$
|
|
|
|
$
|
|
|
||
|
|
Six Months Ended December 31
|
|
||||||
|
Amounts in millions
|
2017
|
|
2016
|
|
||||
|
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
|
$
|
|
|
|
$
|
|
|
|
|
OPERATING ACTIVITIES
|
|
|
|
|
||||
|
Net earnings
|
|
|
|
|
|
|
||
|
Depreciation and amortization
|
|
|
|
|
|
|
||
|
Loss on early extinguishment of debt
|
|
|
|
|
|
|
||
|
Share-based compensation expense
|
|
|
|
|
|
|
||
|
Deferred income taxes
|
(
|
)
|
|
(
|
)
|
|
||
|
Gain on sale of assets
|
(
|
)
|
|
(
|
)
|
|
||
|
Changes in:
|
|
|
|
|
||||
|
Accounts receivable
|
(
|
)
|
|
(
|
)
|
|
||
|
Inventories
|
(
|
)
|
|
(
|
)
|
|
||
|
Accounts payable, accrued and other liabilities
|
|
|
|
(
|
)
|
|
||
|
Other operating assets and liabilities
|
|
|
|
|
|
|
||
|
Other
|
|
|
|
|
|
|
||
|
TOTAL OPERATING ACTIVITIES
|
|
|
|
|
|
|
||
|
INVESTING ACTIVITIES
|
|
|
|
|
||||
|
Capital expenditures
|
(
|
)
|
|
(
|
)
|
|
||
|
Proceeds from asset sales
|
|
|
|
|
|
|
||
|
Acquisitions, net of cash acquired
|
(
|
)
|
|
(
|
)
|
|
||
|
Purchases of short-term investments
|
(
|
)
|
|
(
|
)
|
|
||
|
Proceeds from sales and maturities of short-term investments
|
|
|
|
|
|
|
||
|
Pre-divestiture addition of restricted cash related to the Beauty Brands divestiture
|
|
|
|
(
|
)
|
|
||
|
Cash transferred at closing related to the Beauty Brands divestiture
|
|
|
|
(
|
)
|
|
||
|
Release of restricted cash upon closing of the Beauty Brands divestiture
|
|
|
|
|
|
|
||
|
Change in other investments
|
|
|
|
|
|
|
||
|
TOTAL INVESTING ACTIVITIES
|
(
|
)
|
|
(
|
)
|
|
||
|
FINANCING ACTIVITIES
|
|
|
|
|
||||
|
Dividends to shareholders
|
(
|
)
|
|
(
|
)
|
|
||
|
Change in short-term debt
|
|
|
|
|
|
|
||
|
Additions to long-term debt
|
|
|
|
|
|
|
||
|
Reductions of long-term debt
|
(
|
)
|
|
(
|
)
|
(1)
|
||
|
Treasury stock purchases
|
(
|
)
|
|
(
|
)
|
|
||
|
Impact of stock options and other
|
|
|
|
|
|
|
||
|
TOTAL FINANCING ACTIVITIES
|
(
|
)
|
|
(
|
)
|
|
||
|
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS
|
|
|
|
(
|
)
|
|
||
|
CHANGE IN CASH AND CASH EQUIVALENTS
|
|
|
|
(
|
)
|
|
||
|
CASH AND CASH EQUIVALENTS, END OF PERIOD
|
$
|
|
|
|
$
|
|
|
|
|
(1)
|
|
|
|
|
|
Three Months Ended December 31
|
|
Six Months Ended December 31
|
||||||||||||||||||||
|
|
|
|
Net Sales
|
|
Earnings/(Loss) from Continuing Operations Before Income Taxes
|
|
Net Earnings/(Loss) from Continuing Operations
|
|
Net Sales
|
|
Earnings/(Loss) from Continuing Operations Before Income Taxes
|
|
Net Earnings/(Loss) from Continuing Operations
|
||||||||||||
|
Beauty
|
2017
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Grooming
|
2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Health Care
|
2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Fabric & Home Care
|
2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Baby, Feminine & Family Care
|
2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Corporate
|
2017
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||
|
|
2016
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||
|
Total Company
|
2017
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Beauty
|
|
Grooming
|
|
Health Care
|
|
Fabric & Home Care
|
|
Baby, Feminine & Family Care
|
|
Total Company
|
||||||||||||
|
Goodwill at June 30, 2017
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Acquisitions and divestitures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Translation and other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Goodwill at December 31, 2017
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
||||
|
Intangible assets with determinable lives
|
$
|
|
|
|
$
|
|
|
|
Intangible assets with indefinite lives
|
|
|
|
|
|
||
|
Total identifiable intangible assets
|
$
|
|
|
|
$
|
|
|
|
|
Approximate Percent Change in Estimated Fair Value
|
||||
|
|
+50 bps Discount Rate
|
|
-50 bps Long-term Growth
|
||
|
Shave Care goodwill reporting unit
|
(
|
)%
|
|
(
|
)%
|
|
Gillette indefinite-lived intangible asset
|
(
|
)%
|
|
(
|
)%
|
|
|
Three Months Ended December 31, 2017
|
|
Three Months Ended December 31, 2016
|
||||||||||
|
CONSOLIDATED AMOUNTS
|
Total
|
|
Continuing Operations
|
Discontinued Operations
|
Total
|
||||||||
|
Net earnings
|
$
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
Net earnings attributable to noncontrolling interests
|
(
|
)
|
|
(
|
)
|
|
|
(
|
)
|
||||
|
Net earnings attributable to P&G (Diluted)
|
|
|
|
|
|
|
|
|
|
||||
|
Preferred dividends, net of tax benefit
|
(
|
)
|
|
(
|
)
|
|
|
(
|
)
|
||||
|
Net earnings attributable to P&G available to common shareholders (Basic)
|
$
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
||||||||
|
SHARES IN MILLIONS
|
|
|
|
|
|
||||||||
|
Basic weighted average common shares outstanding
|
|
|
|
|
|
|
|
|
|
||||
|
Effect of dilutive securities
|
|
|
|
|
|
||||||||
|
Conversion of preferred shares
(1)
|
|
|
|
|
|
|
|
|
|
||||
|
Exercise of stock options and other unvested equity awards
(2)
|
|
|
|
|
|
|
|
|
|
||||
|
Diluted weighted average common shares outstanding
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
||||||||
|
PER SHARE AMOUNTS
(3)
|
|
|
|
|
|
||||||||
|
Basic net earnings per common share
|
$
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
Diluted net earnings per common share
|
$
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
Six Months Ended December 31, 2017
|
|
Six Months Ended December 31, 2016
|
||||||||||
|
CONSOLIDATED AMOUNTS
|
Total
|
|
Continuing Operations
|
Discontinued Operations
|
Total
|
||||||||
|
Net earnings
|
$
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
Net earnings attributable to noncontrolling interests
|
(
|
)
|
|
(
|
)
|
|
|
(
|
)
|
||||
|
Net earnings attributable to P&G (Diluted)
|
|
|
|
|
|
|
|
|
|
||||
|
Preferred dividends, net of tax benefit
|
(
|
)
|
|
(
|
)
|
|
|
(
|
)
|
||||
|
Net earnings attributable to P&G available to common shareholders (Basic)
|
$
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
||||||||
|
SHARES IN MILLIONS
|
|
|
|
|
|
||||||||
|
Basic weighted average common shares outstanding
|
|
|
|
|
|
|
|
|
|
||||
|
Effect of dilutive securities
|
|
|
|
|
|
||||||||
|
Conversion of preferred shares
(1)
|
|
|
|
|
|
|
|
|
|
||||
|
Exercise of stock options and other unvested equity awards
(2)
|
|
|
|
|
|
|
|
|
|
||||
|
Diluted weighted average common shares outstanding
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
||||||||
|
PER SHARE AMOUNTS
(3)
|
|
|
|
|
|
||||||||
|
Basic net earnings per common share
|
$
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
Diluted net earnings per common share
|
$
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
(1)
|
|
|
(2)
|
|
|
(3)
|
|
|
|
Three Months Ended December 31
|
|
Six Months Ended December 31
|
||||||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Share-based compensation expense
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Net periodic benefit cost for pension benefits
(1)
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Net periodic benefit cost/(credit) for other retiree benefits
(1)
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
||||
|
(1)
|
|
|
|
Fair Value Asset
|
||||||
|
|
December 31, 2017
|
|
June 30, 2017
|
||||
|
Investments
|
|
|
|
||||
|
U.S. government securities
|
$
|
|
|
|
$
|
|
|
|
Corporate bond securities
|
|
|
|
|
|
||
|
Other investments
|
|
|
|
|
|
||
|
Total
|
$
|
|
|
|
$
|
|
|
|
|
Notional Amount
|
|
Derivative Fair Value Asset/(Liability)
|
||||||||||||
|
|
December 31, 2017
|
|
June 30, 2017
|
|
December 31, 2017
|
|
June 30, 2017
|
||||||||
|
Derivatives in Fair Value Hedging Relationships
|
|
|
|
|
|
|
|
||||||||
|
Interest rate contracts
(1)
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Derivatives in Net Investment Hedging Relationships
|
|
|
|
|
|
|
|
||||||||
|
Foreign exchange contracts
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
Derivatives Not Designated as Hedging Instruments
|
|
|
|
|
|
|
|
||||||||
|
Foreign currency contracts
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
(1)
|
|
|
|
Amount of Gain/(Loss) Recognized in AOCI on Derivatives
|
||||||
|
|
December 31, 2017
|
|
June 30, 2017
|
||||
|
Derivatives in Net Investment Hedging Relationships
|
|
|
|
||||
|
Foreign exchange contracts
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
|
Amount of Gain/(Loss) Reclassified from AOCI into Earnings
|
||||||||||||||
|
|
Three Months Ended December 31
|
|
Six Months Ended December 31
|
||||||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Derivatives in Cash Flow Hedging Relationships
(1)
|
|
|
|
|
|
|
|
||||||||
|
Foreign currency contracts
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
Amount of Gain/(Loss) Recognized in Earnings
|
||||||||||||||
|
|
Three Months Ended December 31
|
|
Six Months Ended December 31
|
||||||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Derivatives in Fair Value Hedging Relationships
(2)
|
|
|
|
|
|
|
|
||||||||
|
Interest rate contracts
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
Debt
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Total
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Derivatives Not Designated as Hedging Instruments
(3)
|
|
|
|
|
|
|
|
||||||||
|
Foreign currency contracts
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
(1)
|
|
|
(2)
|
|
|
(3)
|
|
|
|
Changes in Accumulated Other Comprehensive Income/(Loss) by Component
|
||||||||||||||||||
|
|
Hedges
|
|
Investment Securities
|
|
Pension and Other Retiree Benefits
|
|
Financial Statement Translation
|
|
Total
|
||||||||||
|
Balance at June 30, 2017
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
OCI before reclassifications
(1)
|
(
|
)
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|||||
|
Amounts reclassified from AOCI
(2)
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|||||
|
Net current period OCI
|
(
|
)
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|||||
|
Balance at December 31, 2017
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
(1)
|
|
|
(2)
|
|
|
•
|
Hedges: see Note 7 for classification of gains and losses from hedges in the Consolidated Statements of Earnings.
|
|
•
|
Investment securities: amounts reclassified from AOCI into Other non-operating income, net.
|
|
•
|
|
|
|
|
|
|
|
|
|
Six Months Ended December 31, 2017
|
|
|
||||||||||||||
|
|
Accrual Balance June 30, 2017
|
|
Charges Previously Reported (Three Months Ended September 30, 2017)
|
|
Charges for the Three Months Ended December 31, 2017
|
|
Cash Spent
|
|
Charges Against Assets
|
|
Accrual Balance December 31, 2017
|
||||||||||||
|
Separations
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
Asset-related costs
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
||||||
|
Other costs
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||
|
Total
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
Three Months Ended December 31, 2017
|
|
Six Months Ended December 31, 2017
|
||||
|
Beauty
|
$
|
|
|
|
$
|
|
|
|
Grooming
|
|
|
|
|
|
||
|
Health Care
|
|
|
|
|
|
||
|
Fabric & Home Care
|
|
|
|
|
|
||
|
Baby, Feminine & Family Care
|
|
|
|
|
|
||
|
Corporate
(1)
|
|
|
|
|
|
||
|
Total Company
|
$
|
|
|
|
$
|
|
|
|
(1)
|
|
|
|
Three Months Ended December 31, 2016
|
|
Six Months Ended December 31, 2016
|
|
||||
|
Net sales
|
$
|
|
|
|
$
|
|
|
|
|
Cost of products sold
|
|
|
|
|
|
|
||
|
Selling, general and administrative expense
|
|
|
|
|
|
|
||
|
Interest expense
|
|
|
|
|
|
|
||
|
Other non-operating income/(expense), net
|
|
|
|
|
|
|
||
|
Earnings/(loss) from discontinued operations before income taxes
|
|
|
|
(
|
)
|
|
||
|
Income taxes on discontinued operations
|
|
|
|
|
|
|
||
|
Gain on sale of business before income taxes
|
|
|
|
|
|
|
||
|
Income tax expense/(benefit) on sale of business
|
(
|
)
|
(1)
|
(
|
)
|
(1)
|
||
|
Net earnings from discontinued operations
|
$
|
|
|
|
$
|
|
|
|
|
(1)
|
|
|
|
Six Months Ended December 31, 2016
|
||
|
NON-CASH OPERATING ITEMS
|
|
||
|
Depreciation and amortization
|
$
|
|
|
|
Deferred income tax benefit
|
(
|
)
|
|
|
Before tax gain on sale of businesses
|
|
|
|
|
Net increase in accrued taxes
|
|
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
||
|
Cash taxes paid
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
||
|
Capital expenditures
|
|
|
|
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
|
•
|
Overview
|
|
•
|
Summary of Results –
Six
Months Ended
December 31, 2017
|
|
•
|
Economic Conditions and Uncertainties
|
|
•
|
Results of Operations –
Three and Six Months Ended December 31, 2017
|
|
•
|
Business Segment Discussion –
Three and Six Months Ended December 31, 2017
|
|
•
|
Liquidity and Capital Resources
|
|
•
|
Reconciliation of Measures Not Defined by U.S. GAAP
|
|
Reportable Segments
|
Product Categories (Sub-Categories)
|
Major Brands
|
|
Beauty
|
Hair Care (
Conditioner, Shampoo, Styling Aids, Treatments
)
|
Head & Shoulders, Pantene, Rejoice
|
|
Skin and Personal Care (
Antiperspirant and Deodorant, Personal Cleansing, Skin Care
)
|
Olay, Old Spice, Safeguard, SK-II
|
|
|
Grooming
|
Grooming
(1)
(Shave Care -
Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Shave Care;
Appliances)
|
Braun, Fusion, Gillette, Mach3, Prestobarba, Venus
|
|
Health Care
|
Oral Care (
Toothbrushes, Toothpaste, Other Oral Care
)
|
Crest, Oral-B
|
|
Personal Health Care (
Gastrointestinal, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care
)
|
Prilosec, Vicks
|
|
|
Fabric & Home Care
|
Fabric Care (
Fabric Enhancers, Laundry Additives, Laundry Detergents
)
|
Ariel, Downy, Gain, Tide
|
|
Home Care (
Air Care, Dish Care, P&G Professional, Surface Care
)
|
Cascade, Dawn, Febreze, Mr. Clean, Swiffer
|
|
|
Baby, Feminine & Family Care
|
Baby Care (
Baby Wipes, Diapers and Pants
)
|
Luvs, Pampers
|
|
Feminine Care (
Adult Incontinence, Feminine Care
)
|
Always, Tampax
|
|
|
Family Care (
Paper Towels, Tissues, Toilet Paper
)
|
Bounty, Charmin
|
|
|
(1)
|
The Grooming product category is comprised of the Shave Care and Appliances Global Business Units.
|
|
|
Three Months Ended December 31
|
|
Six Months Ended December 31
|
||||
|
|
Net Sales
|
|
Net Earnings
|
|
Net Sales
|
|
Net Earnings
|
|
Beauty
|
19%
|
|
23%
|
|
19%
|
|
23%
|
|
Grooming
|
10%
|
|
15%
|
|
10%
|
|
14%
|
|
Health Care
|
13%
|
|
16%
|
|
12%
|
|
14%
|
|
Fabric & Home Care
|
31%
|
|
25%
|
|
32%
|
|
27%
|
|
Baby, Feminine & Family Care
|
27%
|
|
21%
|
|
27%
|
|
22%
|
|
Total Company
|
100%
|
|
100%
|
|
100%
|
|
100%
|
|
•
|
Net sales increased 2% to $34 billion. Organic sales, which exclude the impacts of acquisitions and divestitures and foreign exchange, also increased 2%. Organic sales increased 7% in Beauty, 3% in Health Care and 2% in Fabric & Home Care. Organic sales declined 1% in Baby, Feminine & Family Care and 4% in Grooming.
|
|
•
|
Unit volume increased 1%, with organic volume up 2%. Volume increased low single digits in Fabric & Home Care, Health Care and Beauty, was unchanged in Grooming and decreased low single digits in Baby, Feminine & Family Care. Excluding the impacts of minor brand divestitures, organic volume was unchanged in Baby, Feminine & Family Care.
|
|
•
|
Net earnings from continuing operations were
$5.4 billion
,
unchanged
versus the prior year. An increase in earnings before income taxes, driven primarily by sales growth and prior year charges for early debt extinguishment, were offset by an increase in taxes due primarily to the transitional impact of the U.S. Tax Act.
|
|
•
|
Diluted net earnings per share from continuing operations increased 4% to $2.00 due primarily to a reduction in shares outstanding caused by both cash repurchases and shares acquired as part of the prior year Beauty Brands divestiture.
|
|
•
|
Net earnings attributable to Procter & Gamble decreased
$5.2 billion
or
49%
versus the prior year period to
$5.3 billion
. The decline was primarily due to reduction in earnings from discontinued operations related to the base period gain from Beauty Brands divestiture.
|
|
•
|
Core net earnings attributable to Procter & Gamble, which represents net earnings from continuing operations, excluding U.S. tax reform transitional impacts, incremental restructuring charges and the base period charge for early extinguishment of debt, increased 4% to $6.1 billion. Core net earnings per share increased 8% to $2.28 due to the increase in core net earnings and the reduction in shares outstanding.
|
|
•
|
Operating cash flow was
$7.3 billion
. Free cash flow, which is operating cash flow less capital expenditures, was
$5.4 billion
. Adjusted free cash flow productivity, which is the ratio of free cash flow to adjusted net earnings, was
89%
.
|
|
|
Three Months Ended December 31
|
||||
|
Amounts in millions, except per share amounts
|
2017
|
|
2016
|
|
% Chg
|
|
Net sales
|
$17,395
|
|
$16,856
|
|
3%
|
|
Operating income
|
4,003
|
|
3,875
|
|
3%
|
|
Net earnings from continuing operations
|
2,561
|
|
2,561
|
|
—%
|
|
Net earnings from discontinued operations
|
—
|
|
5,335
|
|
N/A
|
|
Net earnings attributable to Procter & Gamble
|
2,495
|
|
7,875
|
|
(68)%
|
|
Diluted net earnings per common share
|
0.93
|
|
2.88
|
|
(68)%
|
|
Diluted net earnings per share from continuing operations
|
0.93
|
|
0.93
|
|
—%
|
|
Core net earnings per common share
|
1.19
|
|
1.08
|
|
10%
|
|
|
|||||
|
|
Three Months Ended December 31
|
||||
|
COMPARISONS AS A % OF NET SALES
|
2017
|
|
2016
|
|
Basis Pt Chg
|
|
Gross profit
|
50.2%
|
|
50.8%
|
|
(60)
|
|
Selling, general & administrative expense
|
27.2%
|
|
27.8%
|
|
(60)
|
|
Operating income
|
23.0%
|
|
23.0%
|
|
—
|
|
Earnings from continuing operations before income taxes
|
23.2%
|
|
19.3%
|
|
390
|
|
Net earnings from continuing operations
|
14.7%
|
|
15.2%
|
|
(50)
|
|
Net earnings attributable to Procter & Gamble
|
14.3%
|
|
46.7%
|
|
(3,240)
|
|
|
Net Sales Change Drivers 2018 vs. 2017 (Three Months Ended December 31)
(1)
|
||||||||||||
|
|
Volume with Acquisitions & Divestitures
|
|
Volume Excluding Acquisitions & Divestitures
|
|
Foreign Exchange
|
|
Price
|
|
Mix
|
|
Other
(2)
|
|
Net Sales Growth
|
|
Beauty
|
2%
|
|
2%
|
|
1%
|
|
—%
|
|
7%
|
|
—%
|
|
10%
|
|
Grooming
|
1%
|
|
1%
|
|
2%
|
|
(4)%
|
|
—%
|
|
—%
|
|
(1)%
|
|
Health Care
|
4%
|
|
4%
|
|
3%
|
|
(1)%
|
|
1%
|
|
—%
|
|
7%
|
|
Fabric & Home Care
|
3%
|
|
4%
|
|
1%
|
|
(1)%
|
|
—%
|
|
—%
|
|
3%
|
|
Baby, Feminine & Family Care
|
(1)%
|
|
(1)%
|
|
1%
|
|
(1)%
|
|
—%
|
|
—%
|
|
(1)%
|
|
Total Company
|
2%
|
|
2%
|
|
1%
|
|
(1)%
|
|
1%
|
|
—%
|
|
3%
|
|
•
|
a 90 basis point decline due to higher commodity costs,
|
|
•
|
a 70 basis point decline from unfavorable product mix (primarily within segments due to disproportionate growth of lower margin products forms in Fabric Care, large sizes and club channels in certain categories),
|
|
•
|
a 50 basis point decline from reduced pricing and
|
|
•
|
a 10 basis point decline from unfavorable foreign exchange.
|
|
•
|
a 340 basis-point reduction from the ongoing impacts of the Tax Act, as the impact of the lower blended U.S. Federal rate was largely offset by the inability to fully credit foreign taxes that were previously included in our estimated annual effective tax rate,
|
|
•
|
a 70 basis-point reduction from activity related to divestitures (30 basis points favorable in the current year versus 40 basis points unfavorable in the prior year),
|
|
•
|
a reduction of approximately 200 basis-points from favorable geographic mix of earnings,
|
|
•
|
a 380 basis-point increase from reduced favorable discrete impacts related to uncertain tax positions (0 basis points in the current year versus 380 basis points in the prior year) and
|
|
•
|
a 210 basis-point increase from the impact of the prior year extinguishment of long-term debt.
|
|
|
Six Months Ended December 31
|
||||
|
Amounts in millions, except per share amounts
|
2017
|
|
2016
|
|
% Chg
|
|
Net sales
|
$34,048
|
|
$33,374
|
|
2%
|
|
Operating income
|
7,738
|
|
7,646
|
|
1%
|
|
Net earnings from continuing operations
|
5,431
|
|
5,436
|
|
—%
|
|
Net earnings from discontinued operations
|
—
|
|
5,217
|
|
N/A
|
|
Net earnings attributable to Procter & Gamble
|
5,348
|
|
10,589
|
|
(49)%
|
|
Diluted net earnings per common share
|
2.00
|
|
3.81
|
|
(48)%
|
|
Diluted net earnings per share from continuing operations
|
2.00
|
|
1.93
|
|
4%
|
|
Core net earnings per common share
|
2.28
|
|
2.11
|
|
8%
|
|
|
|||||
|
|
Six Months Ended December 31
|
||||
|
COMPARISONS AS A % OF NET SALES
|
2017
|
|
2016
|
|
Basis Pt Chg
|
|
Gross profit
|
50.4%
|
|
50.9%
|
|
(50)
|
|
Selling, general & administrative expense
|
27.6%
|
|
27.9%
|
|
(30)
|
|
Operating income
|
22.7%
|
|
22.9%
|
|
(20)
|
|
Earnings from continuing operations before income taxes
|
22.9%
|
|
21.0%
|
|
190
|
|
Net earnings from continuing operations
|
16.0%
|
|
16.3%
|
|
(30)
|
|
Net earnings attributable to Procter & Gamble
|
15.7%
|
|
31.7%
|
|
(1,600)
|
|
|
Net Sales Change Drivers 2018 vs. 2017 (Six Months Ended December 31)
(1)
|
||||||||||||
|
|
Volume with Acquisitions & Divestitures
|
|
Volume Excluding Acquisitions & Divestitures
|
|
Foreign Exchange
|
|
Price
|
|
Mix
|
|
Other
(2)
|
|
Net Sales Growth
|
|
Beauty
|
1%
|
|
1%
|
|
—%
|
|
1%
|
|
5%
|
|
—%
|
|
7%
|
|
Grooming
|
—%
|
|
—%
|
|
2%
|
|
(4)%
|
|
(1)%
|
|
—%
|
|
(3)%
|
|
Health Care
|
2%
|
|
2%
|
|
2%
|
|
—%
|
|
1%
|
|
—%
|
|
5%
|
|
Fabric & Home Care
|
3%
|
|
3%
|
|
—%
|
|
—%
|
|
(1)%
|
|
—%
|
|
2%
|
|
Baby, Feminine & Family Care
|
(1)%
|
|
—%
|
|
1%
|
|
(1)%
|
|
—%
|
|
—%
|
|
(1)%
|
|
Total Company
|
1%
|
|
2%
|
|
1%
|
|
(1)%
|
|
1%
|
|
—%
|
|
2%
|
|
•
|
a 80 basis point decline due to higher commodity costs,
|
|
•
|
a 50 basis point decline from unfavorable product mix (within segments due to disproportionate growth of large sizes and club channels and between segments caused by the disproportionate volume growth in Fabric & Home Care, which has lower than company-average gross margin),
|
|
•
|
a 30 basis point decline from unfavorable foreign exchange and
|
|
•
|
a 30 basis point decline from the impact of reduced pricing.
|
|
•
|
a 180 basis-point reduction from the ongoing impacts of the Tax Act, as the impact of the lower blended U. S. federal rate was largely offset by the inability to fully credit foreign taxes that were previously included in our estimated annual effective tax rate,
|
|
•
|
a 60 basis-point reduction from activity related to divestitures (10 basis points favorable in the current year versus 50 basis points unfavorable in the prior year),
|
|
•
|
a reduction of approximately 150 basis-points from favorable geographic mix of earnings,
|
|
•
|
a 170 basis-point increase from reduced favorable discrete impacts related to uncertain tax positions (20 basis points in the current year versus 190 basis points in the prior year),
|
|
•
|
a 120 basis-point increase from reduced excess tax benefits from share-based compensation (70 basis points in the current year versus 190 basis points in the prior year) and
|
|
•
|
a 100 basis-point increase from the prior year extinguishment of long-term debt.
|
|
|
Three Months Ended December 31, 2017
|
|||||||||||||||||||
|
|
Net Sales
|
|
% Change Versus Year Ago
|
|
Earnings/(Loss) from Continuing Operations Before Income Taxes
|
|
% Change Versus Year Ago
|
|
Net Earnings/(Loss) from Continuing Operations
|
|
% Change Versus Year Ago
|
|||||||||
|
Beauty
|
$
|
3,233
|
|
|
10
|
%
|
|
$
|
853
|
|
|
19
|
%
|
|
$
|
655
|
|
|
21
|
%
|
|
Grooming
|
1,776
|
|
|
(1
|
)%
|
|
531
|
|
|
(14
|
)%
|
|
423
|
|
|
(10
|
)%
|
|||
|
Health Care
|
2,212
|
|
|
7
|
%
|
|
668
|
|
|
10
|
%
|
|
455
|
|
|
8
|
%
|
|||
|
Fabric & Home Care
|
5,434
|
|
|
3
|
%
|
|
1,101
|
|
|
(2
|
)%
|
|
714
|
|
|
(2
|
)%
|
|||
|
Baby, Feminine & Family Care
|
4,613
|
|
|
(1
|
)%
|
|
933
|
|
|
(10
|
)%
|
|
597
|
|
|
(12
|
)%
|
|||
|
Corporate
|
127
|
|
|
(8
|
)%
|
|
(53
|
)
|
|
N/A
|
|
|
(283
|
)
|
|
N/A
|
|
|||
|
Total Company
|
$
|
17,395
|
|
|
3
|
%
|
|
$
|
4,033
|
|
|
24
|
%
|
|
$
|
2,561
|
|
|
—
|
%
|
|
|
Six Months Ended December 31, 2017
|
|||||||||||||||||||
|
|
Net Sales
|
|
% Change Versus Year Ago
|
|
Earnings/(Loss) from Continuing Operations Before Income Taxes
|
|
% Change Versus Year Ago
|
|
Net Earnings/(Loss) from Continuing Operations
|
|
% Change Versus Year Ago
|
|||||||||
|
Beauty
|
$
|
6,371
|
|
|
7
|
%
|
|
$
|
1,689
|
|
|
13
|
%
|
|
$
|
1,287
|
|
|
14
|
%
|
|
Grooming
|
3,353
|
|
|
(3
|
)%
|
|
945
|
|
|
(17
|
)%
|
|
752
|
|
|
(15
|
)%
|
|||
|
Health Care
|
4,114
|
|
|
5
|
%
|
|
1,123
|
|
|
2
|
%
|
|
760
|
|
|
2
|
%
|
|||
|
Fabric & Home Care
|
10,817
|
|
|
2
|
%
|
|
2,280
|
|
|
1
|
%
|
|
1,483
|
|
|
2
|
%
|
|||
|
Baby, Feminine & Family Care
|
9,158
|
|
|
(1
|
)%
|
|
1,897
|
|
|
(9
|
)%
|
|
1,227
|
|
|
(11
|
)%
|
|||
|
Corporate
|
235
|
|
|
(4
|
)%
|
|
(150
|
)
|
|
N/A
|
|
|
(78
|
)
|
|
N/A
|
|
|||
|
Total Company
|
$
|
34,048
|
|
|
2
|
%
|
|
$
|
7,784
|
|
|
11
|
%
|
|
$
|
5,431
|
|
|
—
|
%
|
|
•
|
Volume in Hair Care
increased low single digits
. Developed market volume increased low single digits due to innovation. Volume in developing regions increased low single digits due to product innovation and in-store improvements. Global market share of the Hair Care category
was unchanged
.
|
|
•
|
Volume in Skin and Personal Care
increased mid-single digits
. Volume increased low single digits in developed regions due to product innovation and retail inventory build to support new product launches. Volume increased mid-single digits in
|
|
•
|
Volume in Hair Care
was unchanged
. Volume in developed regions was unchanged and was down low single digits on an organic basis, as growth from innovation was more than offset by lower promotional activity versus the base period. Volume in developing regions volume increased low single digits due to improved in-store executions and product innovation. Global market share of the Hair Care category
was unchanged
.
|
|
•
|
Volume in Skin and Personal Care
increased low single digits
. Volume was unchanged in developed regions as growth from innovation was offset by reductions following increased pricing. Volume increased mid-single digits in developing regions due to product innovation and increased marketing. Global market share of the Skin and Personal Care category
decreased slightly
.
|
|
•
|
Shave Care volume
increased low single digits
. Developed regions volume increased mid-single digits due to increased price competitiveness following price reductions and innovation. Developing regions decreased low single digits due to trade inventory reductions in certain markets. Global market share of the Shave Care category
was unchanged
.
|
|
•
|
Volume in Appliances
increased double digits
. Volume increased double digits in developed regions and high-single digits in developing regions, both due to product innovation and overall market growth. Global market share of the Appliances category
was unchanged
.
|
|
•
|
Volume in Shave Care
decreased low single digits
. Volume in developed regions was unchanged. Developing regions declined low single digits due to trade inventory reductions in certain markets. Global market share of the Shave Care category
decreased half a point
.
|
|
•
|
Volume in Appliances
increased double digits
in both developed and developing regions due to product innovation. Global market share of the Appliances category
increased more than a point
.
|
|
•
|
Oral Care volume
increased low single digits
. Volume increased mid-single digits in developed regions driven by product innovation and marketing investment on premium power brush segment. Volume decreased mid-single digits in developing regions due to trade inventory reductions and competitive activities. Global market share of the Oral Care category
was unchanged
.
|
|
•
|
Volume in Personal Health Care
increased high single digits
. Volume increased mid-single digits in developed regions due to increased consumption from a strong Cough / Cold season. Volume increased double digits in developing regions due in part to distributor inventory build. Global market share of the Personal Health Care category
increased less than half a point
.
|
|
•
|
Oral Care volume
increased low single digits
. Developed regions volume increased mid-single digits driven by product innovation and marketing investments on premium power brush segment. Volume in developing regions declined low single digits due to trade inventory reductions and competitive activities. Global market share of the Oral Care category
decreased slightly
.
|
|
•
|
Volume in Personal Health Care
increased low single digits
. Volume decreased low single digits in developed regions due to relatively lower levels of product innovation versus year ago. Volume in developing regions increased mid-single digits and high single digits on organic basis, due in part to distributer inventory build. Global market share of the Personal Health Care category
increased slightly
.
|
|
•
|
Fabric Care volume
increased low single digits
. Volume in both developed and developing regions grew low single digits due to product innovation and lower pricing driven by promotional spending. Excluding the impact of minor brand divestitures, organic volume grew mid-single digits. Global market share of the Fabric Care category
increased less than half a point
.
|
|
•
|
Home Care volume
increased mid-single digits
. Volume in developed regions increased mid-single digits due to product innovation, increased marketing and lower pricing driven by promotional spending. Volume in developing regions increased high single digits due to marketing investments. Global market share of the Home Care category
was unchanged
.
|
|
•
|
Fabric Care volume
increased low single digits
. Volume in developed regions grew mid-single digits due to product innovation and lower pricing driven by promotional spending. Volume in developing regions grew low single digits due to product innovation and market growth. Global market share of the Fabric Care category
was unchanged
.
|
|
•
|
Home Care volume
increased low single digits
. Volume in developed regions increased low single digits due to product innovation and lower pricing driven by promotional spending. Volume in developing regions increased mid-single digits due to product innovation and marketing investments. Global market share of the Home Care category
was unchanged
.
|
|
•
|
Volume in Baby Care
decreased mid-single digits
. Volume in developed regions declined low single digits due to competitive activities. Volume in developing regions declined high single digits due to volume decline following increased pricing, competitive activity and reduction in trade inventories. Global market share of the Baby Care category
decreased two points
.
|
|
•
|
Volume in Feminine Care
was unchanged
. Organic volume, which excludes the impact of minor brand divestitures, increased low single digits. Organic volume increased mid-single digits in developed regions due to product innovation. Volume decreased low single digits in developing regions due to trade inventory reductions. Global market share of the Feminine Care category
increased less than half a point
.
|
|
•
|
Volume in Family Care, which is predominantly a North American business,
increased low single digits
driven by product innovation, distribution gains and increased media investments. In the U.S., all-outlet share of the Family Care category
decreased less than half a point
.
|
|
•
|
Baby Care volume
decreased mid-single digits
. Volume in developed regions declined low single digits due to competitive activities. Volume in developing regions declined high single digits due to competitive activity, volume decline following
|
|
•
|
Feminine Care volume
was unchanged
. Organic volume, which excludes the impact of minor brand divestitures, increased low single digits. Organic volume increased low single digits in developed regions due to product innovation. Volume increased low single digits in developing regions due to product innovation and market growth. Global market share of the Feminine Care category
increased slightly
.
|
|
•
|
Family Care volume
increased mid-single digits
, driven by product innovation, distribution gains and increased marketing activities. In the U.S., all-outlet share of the Family Care category
increased nearly half a point
.
|
|
Three Months Ended December 31, 2017
|
Net Sales Growth
|
|
Foreign Exchange Impact
|
|
Acquisition/Divestiture Impact
(1)
|
|
Organic Sales Growth
|
|
Beauty
|
10%
|
|
(1)%
|
|
—%
|
|
9%
|
|
Grooming
|
(1)%
|
|
(2)%
|
|
—%
|
|
(3)%
|
|
Health Care
|
7%
|
|
(3)%
|
|
—%
|
|
4%
|
|
Fabric & Home Care
|
3%
|
|
(1)%
|
|
1%
|
|
3%
|
|
Baby, Feminine & Family Care
|
(1)%
|
|
(1)%
|
|
1%
|
|
(1)%
|
|
Total Company
|
3%
|
|
(1)%
|
|
—%
|
|
2%
|
|
Six Months Ended December 31, 2017
|
Net Sales Growth
|
|
Foreign Exchange Impact
|
|
Acquisition/Divestiture Impact
(1)
|
|
Organic Sales Growth
|
|
Beauty
|
7%
|
|
—%
|
|
—%
|
|
7%
|
|
Grooming
|
(3)%
|
|
(2)%
|
|
1%
|
|
(4)%
|
|
Health Care
|
5%
|
|
(2)%
|
|
—%
|
|
3%
|
|
Fabric & Home Care
|
2%
|
|
—%
|
|
—%
|
|
2%
|
|
Baby, Feminine & Family Care
|
(1)%
|
|
(1)%
|
|
1%
|
|
(1)%
|
|
Total Company
|
2%
|
|
(1)%
|
|
1%
|
|
2%
|
|
Fiscal Year-to-Date, December 31, 2017
|
||||
|
Operating Cash Flow
|
|
Capital Spending
|
|
Free Cash Flow
|
|
$7,315
|
|
$(1,900)
|
|
$5,415
|
|
Fiscal Year-to-Date, December 31, 2017
|
||||||
|
Free Cash Flow
|
|
Net Earnings
|
Net U.S. Tax Reform Charge
|
Adjusted Net Earnings
|
|
Adjusted Free Cash Flow Productivity
|
|
$5,415
|
|
$5,431
|
$628
|
$6,059
|
|
89%
|
|
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
(Amounts in Millions Except Per Share Amounts) Reconciliation of Non-GAAP Measures |
||||||||||||||
|
Three Months Ended December 31, 2017
|
||||||||||||||
|
|
AS REPORTED (GAAP)
|
|
INCREMENTAL RESTRUCTURING
|
|
TRANSITIONAL IMPACTS OF U.S. TAX REFORM
|
|
ROUNDING
|
|
NON-GAAP (CORE)
|
|||||
|
COST OF PRODUCTS SOLD
|
8,667
|
|
|
(86
|
)
|
|
—
|
|
|
1
|
|
|
8,582
|
|
|
SELLING, GENERAL AND ADMINISTRATIVE EXPENSE
|
4,725
|
|
|
14
|
|
|
—
|
|
|
(1
|
)
|
|
4,738
|
|
|
OPERATING INCOME
|
4,003
|
|
|
72
|
|
|
—
|
|
|
—
|
|
|
4,075
|
|
|
INCOME TAX ON CONTINUING OPERATIONS
|
1,472
|
|
|
21
|
|
|
(628
|
)
|
|
—
|
|
|
865
|
|
|
NET EARNINGS ATTRIBUTABLE TO P&G
|
2,495
|
|
|
51
|
|
|
628
|
|
|
—
|
|
|
3,174
|
|
|
|
|
|
|
|
|
|
|
|
Core EPS
|
|||||
|
DILUTED NET EARNINGS PER COMMON SHARE
(1)
|
0.93
|
|
|
0.02
|
|
|
0.24
|
|
|
—
|
|
|
1.19
|
|
|
|
|
CHANGE VERSUS YEAR AGO
|
|
|
|
|
|
|
|
|
CORE EPS
|
10
|
%
|
|
|
|
|
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
(Amounts in Millions Except Per Share Amounts) Reconciliation of Non-GAAP Measures |
|||||||||||||||||
|
Three Months Ended December 31, 2016
|
|||||||||||||||||
|
|
AS REPORTED (GAAP)
|
|
DISCONTINUED OPERATIONS
|
|
INCREMENTAL RESTRUCTURING
|
|
EARLY DEBT EXTINGUISHMENT
|
|
ROUNDING
|
|
NON-GAAP (CORE)
|
||||||
|
COST OF PRODUCTS SOLD
|
8,298
|
|
|
—
|
|
|
(128
|
)
|
|
—
|
|
|
—
|
|
|
8,170
|
|
|
SELLING, GENERAL AND ADMINISTRATIVE EXPENSE
|
4,683
|
|
|
—
|
|
|
36
|
|
|
—
|
|
|
1
|
|
|
4,720
|
|
|
OPERATING INCOME
|
3,875
|
|
|
—
|
|
|
92
|
|
|
—
|
|
|
(1
|
)
|
|
3,966
|
|
|
INCOME TAX ON CONTINUING OPERATIONS
|
695
|
|
|
—
|
|
|
21
|
|
|
198
|
|
|
(1
|
)
|
|
913
|
|
|
NET EARNINGS ATTRIBUTABLE TO P&G
|
7,875
|
|
|
(5,335
|
)
|
|
71
|
|
|
345
|
|
|
—
|
|
|
2,956
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Core EPS:
|
||||||
|
DILUTED NET EARNINGS PER COMMON SHARE
(1)
|
2.88
|
|
|
(1.95
|
)
|
|
0.03
|
|
|
0.13
|
|
|
(0.01
|
)
|
|
1.08
|
|
|
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
(Amounts in Millions Except Per Share Amounts) Reconciliation of Non-GAAP Measures |
||||||||||||||
|
Six Months Ended December 31, 2017
|
||||||||||||||
|
|
AS REPORTED (GAAP)
|
|
INCREMENTAL RESTRUCTURING
|
|
TRANSITIONAL IMPACTS OF U.S. TAX REFORM
|
|
ROUNDING
|
|
NON-GAAP (CORE)
|
|||||
|
COST OF PRODUCTS SOLD
|
16,896
|
|
|
(186
|
)
|
|
—
|
|
|
1
|
|
|
16,711
|
|
|
SELLING, GENERAL AND ADMINISTRATIVE EXPENSE
|
9,414
|
|
|
19
|
|
|
—
|
|
|
(1
|
)
|
|
9,432
|
|
|
OPERATING INCOME
|
7,738
|
|
|
167
|
|
|
—
|
|
|
—
|
|
|
7,905
|
|
|
INCOME TAX ON CONTINUING OPERATIONS
|
2,353
|
|
|
41
|
|
|
(628
|
)
|
|
—
|
|
|
1,766
|
|
|
NET EARNINGS ATTRIBUTABLE TO P&G
|
5,348
|
|
|
126
|
|
|
628
|
|
|
—
|
|
|
6,102
|
|
|
|
|
|
|
|
|
|
|
|
Core EPS
|
|||||
|
DILUTED NET EARNINGS PER COMMON SHARE
(1)
|
2.00
|
|
|
0.05
|
|
|
0.23
|
|
|
—
|
|
|
2.28
|
|
|
|
|
CHANGE VERSUS YEAR AGO
|
|
|
|
|
|
|
|
|
CORE EPS
|
8
|
%
|
|
|
|
|
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
(Amounts in Millions Except Per Share Amounts) Reconciliation of Non-GAAP Measures |
|||||||||||||||||
|
Six Months Ended December 31, 2016
|
|||||||||||||||||
|
|
AS REPORTED (GAAP)
|
|
DISCONTINUED OPERATIONS
|
|
INCREMENTAL RESTRUCTURING
|
|
EARLY DEBT EXTINGUISHMENT
|
|
ROUNDING
|
|
NON-GAAP (CORE)
|
||||||
|
COST OF PRODUCTS SOLD
|
16,400
|
|
|
—
|
|
|
(239
|
)
|
|
—
|
|
|
—
|
|
|
16,161
|
|
|
SELLING, GENERAL AND ADMINISTRATIVE EXPENSE
|
9,328
|
|
|
—
|
|
|
59
|
|
|
—
|
|
|
—
|
|
|
9,387
|
|
|
OPERATING INCOME
|
7,646
|
|
|
—
|
|
|
180
|
|
|
—
|
|
|
—
|
|
|
7,826
|
|
|
INCOME TAX ON CONTINUING OPERATIONS
|
1,558
|
|
|
—
|
|
|
36
|
|
|
198
|
|
|
—
|
|
|
1,792
|
|
|
NET EARNINGS ATTRIBUTABLE TO P&G
|
10,589
|
|
|
(5,217
|
)
|
|
144
|
|
|
345
|
|
|
—
|
|
|
5,861
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Core EPS:
|
||||||
|
DILUTED NET EARNINGS PER COMMON SHARE
(1)
|
3.81
|
|
|
(1.88
|
)
|
|
0.05
|
|
|
0.12
|
|
|
0.01
|
|
|
2.11
|
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
|
Item 4.
|
Controls and Procedures
|
|
Item 1.
|
Legal Proceedings
|
|
Item 1A.
|
Risk Factors
|
|
•
|
ordering and managing materials from suppliers;
|
|
•
|
converting materials to finished products;
|
|
•
|
shipping products to customers;
|
|
•
|
marketing and selling products to consumers;
|
|
•
|
collecting, transferring, storing and/or processing customer, consumer, employee, vendor, investor, and other stakeholder information and personal data;
|
|
•
|
summarizing and reporting results of operations, including financial reporting;
|
|
•
|
hosting, processing and sharing, as appropriate, confidential and proprietary research, business plans and financial information;
|
|
•
|
collaborating via an online and efficient means of global business communications;
|
|
•
|
complying with regulatory, legal and tax requirements;
|
|
•
|
providing data security; and
|
|
•
|
handling other processes necessary to manage our business.
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
|
Period
|
Total Number of Shares Purchased
(1)
|
|
Average Price Paid per Share
(2)
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
(3)
|
|
Approximate Dollar Value of Shares That May Yet Be Purchased Under Our Share Repurchase Program
|
||
|
10/01/2017 - 10/31/2017
|
5,501,195
|
|
|
$90.89
|
|
5,501,195
|
|
|
(3)
|
|
11/01/2017 - 11/30/2017
|
5,683,380
|
|
|
$87.98
|
|
5,683,380
|
|
|
(3)
|
|
12/01/2017 - 12/31/2017
|
8,220,899
|
|
|
$91.23
|
|
8,220,899
|
|
|
(3)
|
|
Total
|
19,405,474
|
|
|
$90.18
|
|
19,405,474
|
|
|
|
|
(1)
|
All transactions were made in the open market with large financial institutions. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent third party and does not repurchase stock in connection with cashless exercises.
|
|
(2)
|
Average price paid per share for open market transactions is calculated on a settlement basis and excludes commission.
|
|
(3)
|
On January 23, 2018, the Company stated that in fiscal year 2018 the Company expects to reduce outstanding shares through direct share repurchases at a value of approximately $6 to $8 billion, notwithstanding any purchases under the Company's compensation and benefit plans. Purchases may be made in the open market and/or private transactions and purchases may be increased, decreased or discontinued at any time without prior notice. The share repurchases are authorized pursuant to a resolution issued by the Company's Board of Directors and are expected to be financed by a combination of operating cash flows and issuance of long-term and short-term debt.
|
|
Item 6.
|
Exhibits
|
|
|
|
|
|
|
3-1
|
|
|
Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 11, 2011 and consolidated by the Board of Directors on April 8, 2016) (Incorporated by reference to Exhibit (3-1) of the Company's Form 10-K for the year ended June 30, 2016)
|
|
|
|
|
|
|
3-2
|
|
|
Regulations (as approved by the Board of Directors on April 8, 2016, pursuant to authority granted by shareholders at the annual meeting on October 13, 2009) (Incorporated by reference to Exhibit (3-2) of the Company's Form 10-K for the year ended June 30, 2016)
|
|
|
|
|
|
|
4-1
|
|
|
Indenture, dated as of September 3, 2009, between the Company and Deutsche Bank Trust Company Americas, as Trustee (Incorporated by reference to Exhibit (4-1) of the Company Annual Report on Form 10-K for the year ended June 30, 2015)
|
|
|
|
|
|
|
10-1
|
|
|
Regulations of the Compensation and Leadership Development Committee for The Procter & Gamble 2014 Stock and Incentive Compensation Plan * +
|
|
|
|
|
|
|
10-2
|
|
|
Company’s Form of Separation Letter and Release * +
|
|
|
|
|
|
|
12
|
|
|
Computation of Ratio of Earnings to Fixed Charges
|
|
|
|
|
|
|
31.1
|
|
|
Rule 13a-14(a)/15d-14(a) Certification – Chief Executive Officer
|
|
|
|
|
|
|
31.2
|
|
|
Rule 13a-14(a)/15d-14(a) Certification – Chief Financial Officer
|
|
|
|
|
|
|
32.1
|
|
|
Section 1350 Certifications – Chief Executive Officer
|
|
|
|
|
|
|
32.2
|
|
|
Section 1350 Certifications – Chief Financial Officer
|
|
|
|
|
|
|
101.INS
(1)
|
|
|
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
|
|
|
|
|
|
|
101.SCH
(1)
|
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
101.CAL
(1)
|
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
101.DEF
(1)
|
|
|
XBRL Taxonomy Definition Linkbase Document
|
|
|
|
|
|
|
101.LAB
(1)
|
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
101.PRE
(1)
|
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
*
|
Compensatory plan or arrangement
|
|
|
|
|
+
|
Filed herewith
|
|
|
|
|
(1)
|
XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.
|
|
|
|
|
|
|
|
|
|
|
|
THE PROCTER & GAMBLE COMPANY
|
|
|
|
|
|
|
|
January 23, 2018
|
|
|
|
/s/ VALARIE L. SHEPPARD
|
|
Date
|
|
|
|
(Valarie L. Sheppard)
|
|
|
|
|
|
Senior Vice President, Comptroller and Treasurer
|
|
Exhibit
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
101.INS
(1)
|
|
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
|
|
|
|
|
|
101.SCH
(1)
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
101.CAL
(1)
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
101.DEF
(1)
|
|
XBRL Taxonomy Definition Linkbase Document
|
|
|
|
|
|
101.LAB
(1)
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
101.PRE
(1)
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
+
|
Filed herewith
|
|
|
|
|
(1)
|
XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Suppliers
| Supplier name | Ticker |
|---|---|
| 3M Company | MMM |
| Anheuser-Busch InBev SA/NV | BUD |
| Thermo Fisher Scientific Inc. | TMO |
| CSX Corporation | CSX |
| Illinois Tool Works Inc. | ITW |
| Dow Inc. | DOW |
| FMC Corporation | FMC |
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|